These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 2243353

  • 1. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [Abstract] [Full Text] [Related]

  • 2. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA, Davis KH, Titeler M.
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [Abstract] [Full Text] [Related]

  • 3. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M, Arango V, Hsiung S, Mann JJ, Underwood MD, Liu K, Kassir SA, Ruggiero DA, Tamir H.
    J Neurosci Res; 2000 Sep 15; 61(6):674-85. PubMed ID: 10972964
    [Abstract] [Full Text] [Related]

  • 4. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
    Teitler M, Leonhardt S, Weisberg EL, Hoffman BJ.
    Mol Pharmacol; 1990 Nov 15; 38(5):594-8. PubMed ID: 2233696
    [Abstract] [Full Text] [Related]

  • 5. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD, Gallaher TK, Shih JC.
    Mol Pharmacol; 1993 Jun 15; 43(6):931-40. PubMed ID: 8316224
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ, Peroutka SJ.
    J Neurosci; 1989 Oct 15; 9(10):3482-90. PubMed ID: 2795135
    [Abstract] [Full Text] [Related]

  • 7. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M, Lyon RA, Davis KH, Glennon RA.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3265-71. PubMed ID: 3663239
    [Abstract] [Full Text] [Related]

  • 8. Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia.
    Waeber C, Palacios JM.
    Brain Res Mol Brain Res; 1994 Jul 01; 24(1-4):199-209. PubMed ID: 7968358
    [Abstract] [Full Text] [Related]

  • 9. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 10. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR, Murthy JN, Pluchino RS.
    J Pharmacol Exp Ther; 1992 Apr 26; 261(1):161-5. PubMed ID: 1560361
    [Abstract] [Full Text] [Related]

  • 11. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR.
    Biochem Pharmacol; 1991 Aug 08; 42(5):1099-105. PubMed ID: 1872895
    [Abstract] [Full Text] [Related]

  • 12. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S, Gorospe E, Hoffman BJ, Teitler M.
    Mol Pharmacol; 1992 Aug 08; 42(2):328-35. PubMed ID: 1355262
    [Abstract] [Full Text] [Related]

  • 13. Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand.
    McKenna DJ, Nazarali AJ, Hoffman AJ, Nichols DE, Mathis CA, Saavedra JM.
    Brain Res; 1989 Jan 02; 476(1):45-56. PubMed ID: 2536576
    [Abstract] [Full Text] [Related]

  • 14. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA, Peroutka SJ.
    J Pharmacol Exp Ther; 1988 Dec 02; 247(3):918-25. PubMed ID: 3204523
    [Abstract] [Full Text] [Related]

  • 15. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain.
    Nakada MT, Wieczorek CM, Rainbow TC.
    Neurosci Lett; 1984 Aug 24; 49(1-2):13-8. PubMed ID: 6493586
    [Abstract] [Full Text] [Related]

  • 16. Autoradiographic localization and characterization of [125I]lysergic acid diethylamide binding to serotonin receptors in Aplysia.
    Kadan MJ, Hartig PR.
    Neuroscience; 1988 Mar 24; 24(3):1089-102. PubMed ID: 3380298
    [Abstract] [Full Text] [Related]

  • 17. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J, Hanniford D, Doucette C, Graham E, Poole MF, Ting A, Sherf B, Harrington J, Brunden K, Stricker-Krongrad A.
    Assay Drug Dev Technol; 2005 Dec 24; 3(6):649-59. PubMed ID: 16438660
    [Abstract] [Full Text] [Related]

  • 18. Identification of 5-HT2 receptors, alpha 1-adrenoceptors and amine release sites in rat brain by autoradiography with [125I]7-amino-8-iodo-ketanserin.
    Schotte A, Leysen JE.
    Eur J Pharmacol; 1989 May 11; 172(2):99-106. PubMed ID: 2548884
    [Abstract] [Full Text] [Related]

  • 19. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
    Hoyer D, Pazos A, Probst A, Palacios JM.
    Brain Res; 1986 Jun 18; 376(1):97-107. PubMed ID: 2941113
    [Abstract] [Full Text] [Related]

  • 20. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
    Choudhary MS, Craigo S, Roth BL.
    Mol Pharmacol; 1993 May 18; 43(5):755-61. PubMed ID: 8388989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.